SocialPicks Sentiment:
** v.s.
other stocks
|
This Quarter's Sentiment:
|
|
|
EBS Analysis & Videos »
EBS: Bull or Bear?
FDA, Clinical Trial Calendar Updates: Insmed, Jazz Pharma Await Key Results
EBS
|
|
|
+24.00%
in
196 days
<> Below is a summary of updates to the <font> BioMedReports.com </font> database of over 200 entries included in the <font> FDA and Clinical Trial Calendars </font> . The FDA Calendar includes companies with pending new drug, biological agent, or medical device new product decisions at the FDA sorted by their PDUFA decision deadline dates while the Clinical Trial Calendar encompasses pending clinical trial results (with a focus on late-stage, Phase 3 trials), pending new submissions to the FDA (e.g. NDA, BLA, 510k, PMA, sNDA, sBLA filings), and pending re-submissions to the FDA fo...
|
IBD #1
EBS
|
|
|
-25.20%
in
16 days
(closed on 03/05/09)
|
New Preventive Medicine Index
EBS
|
|
|
-50.02%
in
108 days
(closed on 05/13/09)
One of the major reasons behind Pfizer's (PFE) interest in acquiring Wyeth (WYE) is the latter's focus on products outside of traditional pharmaceuticals – with 60% of Wyeth's revenue from last year derived from biological therapeutics and vaccines. It remains to be seen what happens to Wyeth's proposed deal to acquire Dutch vaccine maker Crucell (CRXL); however since it is much smaller (around $1B) and focuses on the development of vaccines, Pfizer would likely be interested in both companies together. <> With the focus on preven...
|
Drug and health care stocks: The right prescription for 2009
EBS
-11.04%
in
5 days
(closed on 01/10/09)
Filed under: Pfizer (PFE), Newsletters, Johnson and Johnson (JNJ), Bristol-Myers Squibb (BMY), Stocks to Buy, Best Stocks for 2009  Health care has long been considered a recession-resistant business. Given the current economic challenges, it's little surprise that in our survey of favorite stocks for the coming year, a number of leading advisors turned to this classic defensive sector.
<>In this year's Top Stock Picks from 75 advisors report, we found an intriguing group of medical-related stocks, from speculation in emerging biotech to well-established pharmaceutical firms, and from medical pr...
|
Top Five Rated Preventive Medicine Stocks
EBS
|
|
|
-1.58%
in
26 days
(closed on 01/25/09)
The table at my website link below presents statistics and the top five rated companies in the ETF Innovators [ETFI] Preventive Medicine Index. The index includes U.S.-listed companies with market caps of $150M-$45B which are engaged in healthcare business segments including diabetes care companies such as Novo Nordisk (NVO), vaccine makers such as Nabi Biopharma (NABI), diagnostics companies such as China Medical (CMED), and lab services companies such as LabCorp (LH). http://www.etfinnovators.com/2008/12/five-top-rated-preventiv... <> <> The Top 40 Rated companies have ou...
|
Top 40 Rated Emerging Bio-Pharma Stocks
EBS
|
|
|
-10.66%
in
7 days
(closed on 12/29/08)
<> 
The accompanying table [click to enlarge] highlights the Top 40 Rated stocks (sorted alphabetically) in the ETF Innovators [ETFI] Emerging Bio-Pharma Index of biotech and pharmaceutical companies with market caps of $200M-$1.5B. The rating system factors in each company's number of innovative clinical pipeline + marketed products, market cap weighting, and historical stock price return.
The Emerging Bio-Pharma Index has outpaced benchmark ETFs such as iShares Nasdaq Biotech (IBB), PowerShares Dynamic Pharma (PJP),...
|
Have Your Say on Healthcare Reform
EBS
|
|
|
+9.31%
in
15 days
(closed on 12/22/08)
<> Visit the Change.gov website to submit your ideas on healthcare reform as the new Obama-Biden administration prepares for their inauguration on January 20, 2009. Tom Daschle will serve as Secretary of Health & Human Services and is encouraging the nation to share their healthcare experiences and suggestions to improve and reform healthcare in the U.S.
A key feature of the plan is making health insurance coverage possible for all Americans using the existing network of insurers and providers. The plan relies on tax credits for sm...
|
Have Your Say on Healthcare Reform
EBS
|
|
|
+0.00%
in
0 minute
(closed on 12/07/08)
<> Visit the Change.gov website to submit your ideas on healthcare reform as the new Obama-Biden administration prepares for their inauguration on January 20, 2009. Tom Daschle will serve as Secretary of Health & Human Services and is encouraging the nation to share their healthcare experiences and suggestions to improve and reform healthcare in the U.S.
A key feature of the plan is making health insurance coverage possible for all Americans using the existing network of insurers and providers. The plan relies on tax credits for sm...
|
A New Index of Preventive Medicine Cos.
EBS
|
|
|
+1.10%
in
3 days
(closed on 12/07/08)
<> 
The accompanying table [click to enlarge] presents statistics and the top 15 rated companies in the ETF Innovators [ETFI] Preventive Medicine Index. The index includes U.S.-listed companies with market caps of $200M-$60B which are engaged in the following healthcare business segments: vaccine makers, diagnostics, lab services, and diabetes care.
The index has outpaced the overall market, Healthcare Sector SPDR (XLV), HealthShares Diagnostics (HHD), and iShares Nasdaq Biotech (IBB) over the past year, posting ...
|
A New Index of Emerging Biotech & Pharma Companies
EBS
|
|
|
+34.93%
in
12 days
(closed on 12/04/08)
<> 
<>
The accompanying table includes the Top 40 rated companies in the ETF Innovators [ETFI] Emerging Bio-Pharma Index, which includes U.S.-listed companies with market caps between $150M-$1.5B and factors in each companies approved products, late-stage clinical pipeline, trailing 52-week stock price performance, and market cap weighting to calculate a stock rating.
The index has performed much better than its peers over the past year for both the Top 40 Rated (-9%) and all 76 companies (-15%) – doing bett< />< /><><>< />< /><>...
|
Obama-Care Focused on Preventive Medicine
EBS
|
|
|
+1.62%
in
17 days
(closed on 11/22/08)
<> 
In addition to bullish outlooks for generic drugs and Health IT , President-Elect Obama's healthcare plan plans to focus on public health initiatives and mandated coverage of preventive services such as cancer screenings. The accompanying table presents statistics and the top five rated companies in the ETFI Preventive Medicine Index, including vaccine makers such as Emergent BioSolutions (EBS), diabetes care companies such as Novo Nordisk (NVO), diagnostic companies such as Sequenom (SQNM) and Myriad Geneti...
|
People Bullish on EBS
People Bearish on EBS
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
More Resources
|
About Emergent BioSolutions Inc.
- Answers.com
"
